Hussman Strategic Advisors, Inc. Biogen Inc. Transaction History

Hussman Strategic Advisors, Inc.

$351 Million
Q2 2024

A detailed history of Hussman Strategic Advisors, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 6,300 shares of BIIB stock, worth $1.25 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

6,300

Previous 6,300 -0.0%

Holding current value

$1.25 Million

Previous $1.36 Million 7.51%

% of portfolio

0.42%

Previous 0.33%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$275.25 - $318.06 $1.73 Million - $2 Million	6,300 New	6,300 $1.79 Million
Q3 2022 Nov 02, 2022	SELL	$194.69 - $268.46 $4.22 Million - $5.83 Million	-21,700 Closed	0 $0
Q2 2022 Sep 12, 2022	BUY	$187.54 - $223.02 $656,390 - $780,570	3,500 Added 19.23%	21,700 $4.43 Million
Q1 2022 May 04, 2022	BUY	$193.77 - $244.14 $1.01 Million - $1.27 Million	5,200 Added 40.0%	18,200 $3.83 Million
Q4 2021 Jan 31, 2022	BUY	$223.92 - $287.77 $1.18 Million - $1.51 Million	5,250 Added 67.74%	13,000 $3.12 Million
Q3 2021 Nov 01, 2021	BUY	$282.99 - $369.05 $1.32 Million - $1.72 Million	4,650 Added 150.0%	7,750 $2.19 Million
Q2 2021 Aug 03, 2021	SELL	$259.0 - $414.71 $2.38 Million - $3.82 Million	-9,200 Reduced 74.8%	3,100 $1.07 Million
Q4 2020 Feb 01, 2021	SELL	$236.26 - $355.63 $1.32 Million - $1.99 Million	-5,600 Reduced 31.28%	12,300 $3.01 Million
Q3 2020 Nov 02, 2020	SELL	$264.77 - $305.71 $13,238 - $15,285	-50 Reduced 0.28%	17,900 $5.08 Million
Q2 2020 Jul 31, 2020	BUY	$258.66 - $342.55 $1.3 Million - $1.72 Million	5,025 Added 38.88%	17,950 $4.8 Million
Q1 2020 May 01, 2020	BUY	$268.85 - $341.04 $786,386 - $997,542	2,925 Added 29.25%	12,925 $4.09 Million
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $550,150 - $760,175	2,500 Added 33.33%	10,000 $2.97 Million
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $543,600 - $609,700	-2,500 Reduced 25.0%	7,500 $1.75 Million
Q1 2019 May 01, 2019	BUY	$216.71 - $338.96 $541,775 - $847,400	2,500 Added 33.33%	10,000 $2.36 Million
Q4 2018 Feb 01, 2019	BUY	$278.5 - $352.75 $2.09 Million - $2.65 Million	7,500 New	7,500 $2.26 Million
Q3 2018 Oct 31, 2018	SELL	$293.51 - $383.83 $1.47 Million - $1.92 Million	-5,000 Closed	0 $0
Q2 2018 Jul 31, 2018	SELL	$257.52 - $306.91 $1.29 Million - $1.53 Million	-5,000 Reduced 50.0%	5,000 $1.45 Million
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $2.6 Million - $3.68 Million	10,000 New	10,000 $2.74 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Account

Hussman Strategic Advisors, Inc. Biogen Inc. Transaction History